Vyome Holdings, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HIND research report →
About the company
Vyome Holdings, Inc. operates as a healthcare firm currently in its clinical development phase, concentrating on the creation of innovative medicinal treatments designed to address both immuno-inflammatory conditions and infrequent disorders. Founded in 2017, the company extends its market reach throughout the United States and into global territories, headquartered in Princeton, New Jersey.
- CEO
- Venkateswarlu Nelabhotla
- IPO
- 2016
- Employees
- 18
- HQ
- Princeton, NJ, US
Price Chart
- Market Cap
- $12.95M
- P/E
- -0.06
- P/S
- 9.63
- P/B
- 2.02
- EV/EBITDA
- -0.31
- Div Yield
- 0.00%
- Gross Margin
- 48.16%
- Op Margin
- -401.91%
- Net Margin
- -985.46%
- ROE
- -302.13%
- ROIC
- -67.02%
- Revenue
- $319.71K · -96.01%
- Net Income
- $-10,262,007 · -43.93%
- EPS
- $-4.75 · 98.63%
- Op Income
- $-2,747,037
- FCF YoY
- 15.32%
- 52W High
- $18.60
- 52W Low
- $1.75
- 50D MA
- $2.15
- 200D MA
- $3.44
- Beta
- 1.50
- Avg Volume
- 27.09K
Get TickerSpark's AI analysis on HIND
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 13, 25 | Pomichter Stanley D III | other | 17,833 |
| Aug 15, 25 | Pomichter Stanley D III | other | 0 |
| Aug 15, 25 | Jolly Mohanjit | other | 454,456 |
| Aug 15, 25 | Jolly Mohanjit | other | 0 |
| Nov 13, 25 | Tincoff John M. III | other | 17,833 |
| Nov 13, 25 | Sengupta Shiladitya | other | 624,432 |
| Aug 15, 25 | Sengupta Shiladitya | other | 0 |
| Nov 13, 25 | Nelabhotla Venkateswarlu | other | 615,149 |
| Aug 15, 25 | Nelabhotla Venkateswarlu | other | 7 |
| Aug 15, 25 | Tincoff John M. III | other | 0 |
Our HIND coverage
Recent articles, reports, and earnings notes.
No research on HIND yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HIND report →Similar companies
Peers in the same neighborhood.